Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.54 +0.07 (+14.77%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Prepaid Assets (2020 - 2026)

Pasithea Therapeutics (KTTA) posted Prepaid Assets of $1.8 million for Q1 2026, up 125.46% sequentially from $811456.0 in Q4 2025, and up 194.51% YoY from $621208.0 in Q1 2025.

Pasithea Therapeutics (KTTA) Prepaid Assets (2020 - 2026) Analysis & Trends

Pasithea Therapeutics has reported Prepaid Assets for 7 years, with the latest figure at $1.8 million in Q1 2026.

  • Quarterly Prepaid Assets rose 194.51% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 194.51% YoY) and the FY2025 annual result came in at $811456.0, up 168.12% from the prior year.
  • Prepaid Assets improved to $1.8 million in Q1 2026 per KTTA's latest filing, from $811456.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $1.8 million in Q1 2026 and troughed at $19665.0 in Q3 2025.
  • A 5-year average of $525773.7 and a median of $452195.0 in 2023 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets sank 87.7% in 2023, then jumped 493.61% in 2025.
  • Over 5 years, Prepaid Assets stood at $262992.0 in 2022, then plunged by 60.19% to $104707.0 in 2023, then surged by 189.04% to $302641.0 in 2024, then soared by 168.12% to $811456.0 in 2025, then soared by 125.46% to $1.8 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.8 million, $811456.0, and $19665.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Pasithea Therapeutics 16.97 Mn 16.97 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.83 Mn
Dec 31, 2025 811,456.00
Sep 30, 2025 19,665.00
Jun 30, 2025 1.30 Mn
Mar 31, 2025 621,208.00
Dec 31, 2024 302,641.00
Sep 30, 2024 98,333.00
Jun 30, 2024 570,242.00
Mar 31, 2024 104,649.00
Dec 31, 2023 104,707.00
Sep 30, 2023 106,511.00
Jun 30, 2023 452,195.00
Mar 31, 2023 262,992.00
Dec 31, 2022 262,992.00
Sep 30, 2022 865,985.00
Jun 30, 2022 594,613.00
Mar 31, 2022 628,740.00
Dec 31, 2021 333,751.00
Sep 30, 2021 468,527.00
Dec 31, 2020 4,308.00